Prevention of Adolescent Major Depression

Adolescents Coping With Stress: Prevention of Adolescent Major Depression in School Health Care

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00611052

Acronym

CWSA-Fin

Enrollment

Registered

2008-02-08

Start date

2008-03-31

Completion date

2013-12-31

Last updated

2016-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Disorder

Keywords

Depressive Disorder, Depressive Disorder, Major, Mental Health, Prevention

Brief summary

The main purpose of this study is to assess the effect of a cognitive group intervention on prevention of major depression in 14-15-year-old adolescents. Moreover, the effect on other selected mental health parameters are investigated.

Interventions

BEHAVIORALthe Adolescent Coping with Stress

A group cognitive intervention, manualized and highly structured. Includes 8 sessions (á 1.5 hours) and a booster session 6 months after termination of the actual intervention. Groups leaders are specifically trained for this course.

BEHAVIORALTreatment as usual

The usual treatment received by the adolescent with mild to moderate self-reported depressive symptoms in school health care.

OTHERusual health education

usual health education given by the school nurses, targeted for healthy controls with no depressive symptoms according to the self-report scale

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Investigator)

Eligibility

Sex/Gender

ALL

Age

14 Years to 16 Years

Healthy volunteers

Inclusion criteria

* mild to moderate level depressive symptoms (RBDI self-report scale) * adequate knowledge of the Finnish language * informed consent from the adolescent (all) and his/her parent (under 15 years) * healthy controls comprise subjects with no depressive symptoms

Exclusion criteria

* ongoing major depression, dysthymia or bipolar disorder * ongoing other severe psychiatric illness precluding group participation * mental retardation

Design outcomes

Primary

Measure	Time frame
Major depression (diagnostic interview) High level of depressive symptoms (self-report scale)	3 months, 6 months, 12months, 24 months, 36 months

Secondary

Measure	Time frame
Suicidality (diagnostic interview, self-report scale)	3 months, 6 months, 12 months, 24 months, 36 months

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026